加快分子动力学研究小分子抑制剂和糖酸突变酶1之间的相互作用机制
Yanqi Sun1, Chaoyue Jia1, Shaolong Zhang1
1School of Physics and Electronics, Shandong Normal University, Jinan, 250358, China. liuxinguo@sdnu.edu.cn.
Physical chemistry chemical physics : PCCP
|October 15, 2024
概括
针对糖酸突变酶1 (PGAM1) 的新型小分子显示出对癌症治疗的希望. 分子模拟揭示了关键相互作用和增强的结合,确定了抑制PGAM1活性的潜在药物标.
科学领域:
- 生物化学和分子生物学
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 在全球范围内,癌症仍然是导致死亡的首要原因,在中国有很大的影响.
- 糖酸突变酶1 (PGAM1) 是糖解中的关键酶,与瘤生长有关.
- 基于 antraquinone 的小分子已经通过向PGAM1.1,证明了抗癌潜力.
研究的目的:
- 研究由新型抑制剂诱导的PGAM1的结合机制和构造变化.
- 评估具有 antraquinone 核心的小分子在抑制 PGAM1.1 的有效性.
- 为未来的药物设计确定参与PGAM1抑制剂相互作用的关键残留物.
主要方法:
- 用加速分子动力学 (aMD) 模拟来分析结构动力学.
- 动态交叉相关图 (DCCM) 和主要组件分析 (PCA) 评估了运动行为.
- 分子力学概括 诞生表面积 (MM-GBSA) 和自由能量分解被用来研究结合亲和力和相互作用.
主要成果:
- 抑制剂结合显著改变了PGAM1的动态行为和结构格局.
- 与8KX相比,化合物9HU和HKB对PGAM1的结合增强,这归因于特定的化学修饰.
- 鉴定出疏水性相互作用对抑制剂结合至关重要,并突出显示了F22,R90和Y92等关键残留物.
结论:
- 开发针对PGAM1的基于 antraquinone的小分子是癌症治疗的可行策略.
- 特定的结构修改,如硫胺逆转和三甲基替代,增强抑制剂的功效.
- 确定了关键的PGAM1残留物,为新型抗癌药物的合理设计提供了有价值的目标.
相关概念视频
02:54Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
01:22Amplifying Signals via Enzymatic Cascade
8.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.3K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
01:30Enzyme Inhibition
78.0K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.0K